Document is current
Any future updates will be listed below
-
Authors
Itzhaki, Ruth F. https://orcid.org/0000-0001-5167-5276
Golde, Todd E. https://orcid.org/0000-0003-1867-7071
Heneka, Michael T. https://orcid.org/0000-0003-4996-1630
Readhead, Ben https://orcid.org/0000-0003-4353-9965
- License Information
-
More Information
Article History
Accepted: 7 February 2020
First Online: 9 March 2020
Competing interests
: T.E.G. is a co-founder and is on the scientific advisory board (SAB) of Lacerta Therapeutics. He is an SAB member for Promis Therapeutics and has served on SABs for Abbvie, Pfizer, Novartis, Roche/Genetic, Bristol Myers Squibb, Eli Lilly and Biogen. He is an inventor on a number of patents relating to Alzheimer disease therapeutics. He receives funding from the NIH, the Facial Pain Research Foundation and the State of Florida. M.T.H. serves as an advisory board member for IFM Therapeutics, Alector and Tiaki. The other authors declare no competing interests.
